Dec 06,2022

Effect of CGM Access Expansion on Uptake Among Patients on Medicaid With Diabetes

Current studies on continuous glucose monitor (CGM) uptake are revealing for significant barriers and inequities for CGM use among patients from socially underprivileged communities. This study explores the effect of full subsidies regardless of diabetes type on CGM uptake and HbA1c outcomes in a U.S. adult patient population on Medicaid.

CLINICAL STUDY

#cgm

View Analyst & Ambassador Comments
Go to original news
Dec 06,2022

New International Consensus on CGM Clinical Trial Metrics Aims to Spur Diabetes Treatment Advances

The diaTribe Foundation, Advanced Technologies & Treatments for Diabetes (ATTD), and the Time in Range Coalition announced today a new international consensus regarding continuous glucose monitoring (CGM) metrics for clinical trials to help accelerate the development of new and improved treatments for people living with diabetes. There is international recognition of the importance of TIR as an actionable metric for daily diabetes management and a means to improve long-term health outcomes. As such, earlier this year, the diaTribe Foundation, ATTD, and the Time in Range Coalition convened a group of international experts to discuss and reach consensus on the role of CGMs and CGM-derived metrics in clinical trials for diabetes treatment.

#cgm

View Analyst & Ambassador Comments
Go to original news
Dec 08,2022

Dexcom G7 Receives FDA Clearance: The Most Accurate Continuous Glucose Monitoring System Cleared in the U.S.

DexCom, Inc. announced today the FDA has cleared the next-generation Dexcom G7 Continuous Glucose Monitoring (CGM) System for people with all Types of diabetes ages two years and older. Dexcom is working closely with its insulin pump partners to integrate Dexcom G7 into current and future automated insulin delivery systems as quickly as possible.

REGULATORY FDA

#cgm

#insulin pump

#telehealth

View Analyst & Ambassador Comments
Go to original news
Dec 12,2022

Dexcom Canada Partners With Green Shield and The Health Depot to Offer Plan Members a Comprehensive Digital Diabetes Care Experience

Dexcom, Inc.a announced today its partnership with Green Shield and The Health Depot digital pharmacy to provide Green Shield plan members with convenient access to the Dexcom G6 rtCGM System combined with virtual diabetes coaching support. Green Shield plan members eligible for Dexcom G6 rtCGM coverage who register for this new Digital Diabetes Care Program, delivered by The Health Depot, will have exclusive access to convenient and coordinated diabetes management support services

COLLABORATION PARTNERSHIP

#insurance

#cgm

#coaching

View Analyst & Ambassador Comments
Go to original news
Dec 21,2022

FDA clearance for Dexcom G7 marks a ‘huge leap’ forward, COO Jake Leach says

Dexcom (Nasdaq:DXCM) CEO Kevin Sayer told Drug Delivery Business News that its next-generation CGM would be “wonderful.” At the time, he said enthusiasm over the Dexcom G7 sat at an all-time high. The Dexcom G7 demonstrated exciting results in glucose monitoring in a number of clinical trials. One study highlights its accuracy, and another demonstrates success with pediatric users. Dexcom announced its international rollout for G7 in October. The system won CE mark in March.

PRODUCT

#cgm

View Analyst & Ambassador Comments
Go to original news
Dec 21,2022

Abbott FreeStyle Libre 3 links with automated insulin delivery system for use in Europe

Abbott today announced compatibility between its FreeStyle Libre 3 sensor and the mylife Loop from Ypsomed and CamDiab. Combined, the technologies create a smart, automated process for insulin delivery based on real-time glucose data.

PRODUCT

#closed loop

#cgm

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Dec 27,2022

The 10 biggest diabetes tech stories from 2022

2022 represented a landmark year for next-generation diabetes tech. Here are the biggest stories from the past year. Some companies picked up major regulatory nods such as Dexcom and Senseonics. Others experienced major regulatory setbacks like Medtronic.

#insulin pump

#cgm

#closed loop

View Analyst & Ambassador Comments
Go to original news
Nov 02,2022

Health Canada grants licence for Medtronic’s MiniMed 780G insulin pump

Health Canada has granted a licence to Medtronic Canada for the MiniMed 780G insulin pump system for use by type 1 diabetes patients.The device has been designed for the continuous delivery of basal insulin at selectable rates and amounts. With an advanced hybrid closed loop (AHCL), the MiniMed 780G system is claimed to be Canada’s first and only insulin pump to automatically adjust sugars every five minutes.

PRODUCT

#cgm

#closed loop

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Nov 03,2022

Senseonics and Ascensia Announce a Collaboration with the Nurse Practitioner Group Designed to Expand Patient Access by Providing In-Office and At-Home Insertion Options for Eversense® E3 Continuous Glucose Monitoring System (CGM)

Senseonics Holdings, Inc. and Ascensia Diabetes Care, exclusive distributor of Eversense® CGM Systems, today announced the launch of a collaboration with the Nurse Practitioner Group (NPG), a leader in multidisciplinary health services and medical staffing solutions. Senseonics, Ascensia and NPG view this collaboration as a scalable solution with the goal of expanding access to the Eversense E3 CGM System, enhancing the patient experience, streamlining the Eversense workflow for health care providers who elect not to do insertions themselves, thus broadening the universe of clinicians who prescribe Eversense.

COLLABORATION PARTNERSHIP

#institution

#cgm

View Analyst & Ambassador Comments
Go to original news
Nov 08,2022

ASCENSIA DIABETES CARE ANNOUNCES GLOBAL INTEGRATION OF THE EVERSENSE CGM SYSTEM WITH APPLE HEALTH

Ascensia Diabetes Care announces that the Eversense® CGM app has been updated globally to seamlessly integrate with Apple Health. This means that people with diabetes using Eversense CGM Systems will now also have the option to view their glucose data within the Apple Health app, alongside other health metrics on the iPhone’s widely used health and wellbeing platform.

PRODUCT

#cgm

#mobile app

View Analyst & Ambassador Comments
Go to original news
Subscribe to CGM